You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back


eMC, electronic Medicines Compendium; GB, Great Britian; NI, Northern Ireland; SPC, Summary of Product Characteristics; PIL, Patient Information Leaflet

Blenrep is a registered trademark of the GlaxoSmithKline group of companies

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can so report side effects directly via the Yellow Card Scheme at . By reporting side effects you can help provide more information on the safety of this medicine.


This medicine is subject to additional monitoring. This will allow quick identification of new safety information.
Adverse events should be reported. Reporting forms and information can be found at or search
for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221
441 or